NFKB1 and cancer: However, previous reports also show that Bay 11–7085 demonstrates anti-cancer activity in an NF-κB -independent manner, all of which indicates that Bay 11-7085 may possess multiple bioactivities (Azevedo et al., 2015; Vasu Govardhana Reddy et al., 2004).